Last10K.com

Cvs Caremark Corp (CVS) SEC Filing 10-K Annual report for the fiscal year ending Saturday, December 31, 2011

Cvs Health Corp

CIK: 64803 Ticker: CVS

Exhibit 99.1

 

Investor Contact:

 

Nancy Christal

 

Media Contact:

 

Eileen H. Boone

 

 

Senior Vice President

 

 

 

Senior Vice President

 

 

Investor Relations

 

 

 

Corporate Communications &

 

 

(914) 722-4704

 

 

 

Community Relations

 

 

 

 

 

 

(401) 770-4561

 

FOR IMMEDIATE RELEASE

 

CVS CAREMARK REPORTS FOURTH QUARTER AND FULL YEAR RESULTS

2012 GUIDANCE RAISED TO REFLECT ANTICIPATED FIRST QUARTER BENEFIT OF PRESCRIPTION TRANSFERS FROM WALGREENS

 

Fourth Quarter Year-Over-Year Highlights:

·                  Net revenues increased 15.2% to a record $28.3 billion, with Pharmacy Services up 32.4% and Retail Pharmacy up 4.0%

·                  Retail Pharmacy segment same stores sales increased 2.5%

·                  Adjusted EPS of $0.89, up 16.2% excluding $0.03 per share tax benefit in prior year; GAAP diluted EPS from continuing operations of $0.84

 

Full Year Highlights:

·                  Net revenues increased 11.8% to a record $107.1 billion, with Pharmacy Services up 24.9% and Retail Pharmacy up 3.9%

·                  Retail Pharmacy segment same store sales increased 2.3%

·                  Adjusted EPS of $2.80, up 5.9% excluding $0.03 per share tax benefit in prior year; GAAP diluted EPS from continuing operations of $2.59

·                  Generated free cash flow of $4.6 billion; cash flow from operations of $5.9 billion

 

2012 Guidance:

·                  Full-year Adjusted EPS of $3.18 to $3.28; GAAP diluted EPS from continuing operations of $2.96 to 3.06

·                  First quarter Adjusted EPS from continuing operations of $0.61 to $0.63; GAAP diluted EPS from continuing operations of $0.55 to $0.57

·                  Expect to generate full year free cash flow of $4.6 to $4.9 billion; cash flow from operations of $6.2 to $6.4 billion

 

WOONSOCKET, RHODE ISLAND, February 8, 2012 - CVS Caremark Corporation (NYSE: CVS) today announced revenues, operating profit and net income for the three months and year ended December 31, 2011.

 

Revenues

 

Net revenues for the three months ended December 31, 2011, increased 15.2% or $3.7 billion, to $28.3 billion, up from $24.6 billion in the three months ended December 31, 2010. For the year ended December 31, 2011, total revenue increased 11.8% or $11.3 billion, to $107.1 billion, compared to $95.8 billion for the year ended December 31, 2010.

 

1


The following information was filed by Cvs Health Corp (CVS) on Wednesday, February 8, 2012 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition. It may be helpful to assess the quality of management by comparing the information in the press release to the information in the accompanying 10-K Annual Report statement of earnings and operation as management may choose to highlight particular information in the press release.

View differences made from one year to another to evaluate Cvs Health Corp's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Cvs Health Corp.

Continue

Assess how Cvs Health Corp's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Cvs Health Corp's Definitive Proxy Statement (Form DEF 14A) filed after their 2012 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

Tools

Financial Statements, Disclosures and Schedules

Inside this 10-K Annual Report

Document And Entity Information
Consolidated Balance Sheets
Consolidated Balance Sheets (parenthetical)
Consolidated Statements Of Cash Flows
Consolidated Statements Of Income
Consolidated Statements Of Shareholders' Equity
Borrowing And Credit Agreements
Borrowing And Credit Agreements (details)
Borrowing And Credit Agreements (tables)
Business Combination
Business Combination (details)
Commitments And Contingencies
Commitments And Contingencies (details)
Discontinued Operations
Discontinued Operations (details)
Discontinued Operations (tables)
Earnings Per Common Share
Earnings Per Common Share (details)
Earnings Per Common Share (tables)
Employee Stock Ownership Plan
Employee Stock Ownership Plan (details)
Goodwill And Other Intangibles
Goodwill And Other Intangibles (details)
Goodwill And Other Intangibles (tables)
Income Taxes
Income Taxes (details)
Income Taxes (tables)
Leases
Leases (details)
Leases (tables)
Medicare Part D
Pension Plans And Other Postretirement Benefits
Pension Plans And Other Postretirement Benefits (details)
Quarterly Financial Information (unaudited)
Quarterly Financial Information (unaudited) (details)
Quarterly Financial Information (unaudited) (tables)
Segment Reporting
Segment Reporting (details)
Segment Reporting (tables)
Share Repurchase Programs
Share Repurchase Programs (details 2)
Share Repurchase Programs (details)
Significant Accounting Policies
Significant Accounting Policies (details 2)
Significant Accounting Policies (details 3)
Significant Accounting Policies (details 4)
Significant Accounting Policies (details 5)
Significant Accounting Policies (details)
Significant Accounting Policies (policies)
Significant Accounting Policies (tables)
Stock Incentive Plans
Stock Incentive Plans (details 2)
Stock Incentive Plans (details 3)
Stock Incentive Plans (details)
Stock Incentive Plans (tables)
Ticker: CVS
CIK: 64803
Form Type: 10-K Annual Report
Accession Number: 0001104659-12-010850
Submitted to the SEC: Fri Feb 17 2012 1:38:28 PM EST
Accepted by the SEC: Fri Feb 17 2012
Period: Saturday, December 31, 2011
Industry: Retail Drug Stores And Proprietary Stores

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/cvs/0001104659-12-010850.htm